Sentence examples for weakly responded from inspiring English sources
However, cells only weakly responded to stimulation with IL-6.
However, one of the four bulls weakly responded to fasudil.
In contrast, the mPAP of yaks weakly responded to fasudil and the difference did not reach significance.
Regarding to the enhancement or inhibition of stress stimulation, the SRN involved in PVN would be determined if inhibited obviously with the intravenous injection of hydrocortisone, slightly inhibited with testosterone and weakly responded to estrogen separately.
On the other hand, U3C cells overexpressing IRF9 only weakly responded to IFNα, in agreement with the lack of intrinsic transcriptional capacity of IRF9 [ 33] and limited amount of phosphorylated STAT2 in these cells after treatment (not shown).
Platelets from His/Tyr452 healthy subjects more weakly responded to serotonin stimulation compared with platelets from His/His452 individuals (3.2 ± 2.6-fold versus 9.6 ± 8.6-fold increase in aggregation, P = 0.017 by Kolmogorov Smirnov test and P = 0.003 after correction for baseline adenosine diphosphate-induced aggregation values).
In another research context, a somewhat lower fold change threshold might be used which would show more weakly responding genes (transcripts).
Then, the image patch will strongly respond to the part of the image containing the facial feature, and weakly respond everywhere else. Figure 8 shows the training process: the patches for detecting eye corners and pupils are being trained.
The DLS below CBM (α type) with localized wavefunctions do not contribute to conductivity, though occupied by electrons and weakly respond to external perturbations such as pressure and temperature.
A fold change value of at least 1.5 was chosen to exclude a large proportion of weakly responding genes and identify more pronounced changes in regulation, and accordingly, more suitable candidate genes (transcripts).
Such possibly persistent induction of P lGFs or other pro-proliferative factors might play a role in PDR that weakly respond to anti-VEGF therapies.
